02.06.2024
Prevent & Delay
$22,755,683.00
41 months
Continuation 2 of the GPPAD-02-Study: Identification of infants with increased type 1 diabetes risk for enrollment into primary prevention trials
Funding supports screening of newborns to identify those at high genetic risk of developing T1D-associated autoimmunity.